Trail Resistance Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness by Suppressing PTEN via miR-221 in Breast Cancer

PLoS ONE- United States

doi 10.1371/journal.pone.0099067

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity Through PTEN and TIMP3 Downregulation

Cancer Cell
Cancer ResearchOncologyCell Biology
2009English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

Loss of TBK1 Induces Epithelial-Mesenchymal Transition in the Breast Cancer Cells by ER Downregulation

Cancer Research
Cancer ResearchOncology
2013English

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

miR-15b Promotes Epithelial-Mesenchymal Transition by Inhibiting SMURF2 in Pancreatic Cancer

International Journal of Oncology
Cancer ResearchOncology
2015English

Propofol Inhibits Proliferation and Epithelial-Mesenchymal Transition of McF-7 Cells by Suppressing miR-21 Expression

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy